Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice

BMC Biology

Volumn 9, Issue , 2011, Pages

  Sargin, Derya ^a   El Kordi, Ahmed ^a,b   Agarwal, Amit ^a   Müller, Michael ^b,c   Wojcik, Sonja M ^a   Hassouna, Imam ^a   Sperling, Swetlana ^a   Nave, Klaus Armin ^a,b   Ehrenreich, Hannelore ^a,b  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b Deutsche Forschungsgemeinschaft   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

ERYTHROPOIETIN RECEPTOR; RECOMBINANT ERYTHROPOIETIN;

ANIMAL; ARTICLE; ATTENTION; BRAIN CORTEX; COGNITION; DRUG EFFECT; GENETICS; HIPPOCAMPUS; HUMAN; IMPULSIVENESS; LEARNING; MALE; MEMORY; METABOLISM; MOUSE; PHYSIOLOGY; PYRAMIDAL NERVE CELL; SOCIAL BEHAVIOR; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ATTENTION; CEREBRAL CORTEX; COGNITION; ERYTHROPOIETIN, RECOMBINANT; HIPPOCAMPUS; HUMANS; IMPULSIVE BEHAVIOR; LEARNING; MALE; MEMORY; MICE; PYRAMIDAL CELLS; RECEPTORS, ERYTHROPOIETIN; SOCIAL BEHAVIOR;

EID: 79955133405     PISSN: None     EISSN: 17417007     Source Type: Journal    
DOI: 10.1186/1741-7007-9-27     Document Type: Article

References (59)

1. Ehrenreich H, Bartels C, Sargin D, Stawicki S, Krampe H. Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition. J Ren Nutr 2008, 18:146-153. 10.1053/j.jrn.2007.10.029, 18089462.
2. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev 1992, 72:449-489.
3. Jelkmann W. Effects of erythropoietin on brain function. Curr Pharm Biotechnol 2005, 6:65-79.
4. Masuda S, Nagao M, Takahata K, Konishi Y, Gallyas F, Tabira T, Sasaki R. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem 1993, 268:11208-11216.
5. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 1994, 269:19488-19493.
6. Sadamoto Y, Igase K, Sakanaka M, Sato K, Otsuka H, Sakaki S, Masuda S, Sasaki R. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun 1998, 253:26-32. 10.1006/bbrc.1998.9748, 9875214.
7. Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 2005, 6:484-494. 10.1038/nrn1687, 15928718.
8. Sirén AL, Fasshauer T, Bartels C, Ehrenreich H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 2009, 6:108-127. 10.1016/j.nurt.2008.10.041, 19110203.
9. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001, 412:641-647. 10.1038/35088074, 11493922.
10. Sirén AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, Keenan S, Gleiter C, Pasquali C, Capobianco A, Mennini T, Heumann R, Cerami A, Ehrenreich H, Ghezzi P. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 2001, 98:4044-4049. 10.1073/pnas.051606598, 31176, 11259643.
11. Byts N, Samoylenko A, Fasshauer T, Ivanisevic M, Hennighausen L, Ehrenreich H, Sirén AL. Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin. Cell Death Differ 2008, 15:783-792. 10.1038/cdd.2008.1, 18259195.
12. Sargin D, Friedrichs H, El-Kordi A, Ehrenreich H. Erythropoietin as neuroprotective and neuroregenerative treatment strategy: Comprehensive overview of 12 years of preclinical and clinical research. Best Pract Res Clin Anaestesiol 2010, 24(4):573-594.
13. Ehrenreich H, Hinze-Selch D, Stawicki S, Aust C, Knolle-Veentjer S, Wilms S, Heinz G, Erdag S, Jahn H, Degner D, Ritzen M, Mohr A, Wagner M, Schneider U, Bohn M, Huber M, Czernik A, Pollmächer T, Maier W, Sirén AL, Klosterkötter J, Falkai P, Rüther E, Aldenhoff JB, Krampe H. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry 2007, 12:206-220. 10.1038/sj.mp.4001907, 17033631.
14. Wüstenberg T, Begemann M, Bartels C, Gefeller O, Stawicki S, Hinze-Selch D, Mohr A, Falkai P, Aldenhoff JB, Knauth M, Nave KA, Ehrenreich H. Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Mol Psychiatry 2011, 16:26-36. 10.1038/mp.2010.51, 20479759.
15. Ehrenreich H, Fischer B, Norra C, Schellenberger F, Stender N, Stiefel M, Sirén AL, Paulus W, Nave KA, Gold R, Bartels C. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 2007, 130:2577-2588. 10.1093/brain/awm203, 17728357.
16. Neubauer AP, Voss W, Wachtendorf M, Jungmann T. Erythropoietin improves neurodevelopmental outcome of extremely preterm infants. Ann Neurol 2010, 67:657-666.
17. Adamcio B, Sargin D, Stradomska A, Medrihan L, Gertler C, Theis F, Zhang M, Müller M, Hassouna I, Hannke K, Sperling S, Radyushkin K, El-Kordi A, Schulze L, Ronnenberg A, Wolf F, Brose N, Rhee JS, Zhang W, Ehrenreich H. Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol 2008, 6:37. 10.1186/1741-7007-6-37, 2562991, 18782446.
18. El-Kordi A, Radyushkin K, Ehrenreich H. Erythropoietin improves operant conditioning and stability of cognitive performance in mice. BMC Biol 2009, 7:37. 10.1186/1741-7007-7-37, 2715378, 19586522.
19. Miskowiak K, O'Sullivan U, Harmer CJ. Erythropoietin enhances hippocampal response during memory retrieval in humans. J Neurosci 2007, 27:2788-2792. 10.1523/JNEUROSCI.5013-06.2007, 17360900.
20. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000, 97:10526-10531. 27058, 10984541.
21. Ehrenreich H, Degner D, Meller J, Brines M, Behe M, Hasselblatt M, Woldt H, Falkai P, Knerlich F, Jacob S, von Ahsen N, Maier W, Brück W, Rüther E, Cerami A, Becker W, Sirén AL. Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry 2004, 9:42-54.
22. Banks WA, Jumbe NL, Farrell CL, Niehoff ML, Heatherington AC. Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa. Eur J Pharmacol 2004, 505:93-101. 10.1016/j.ejphar.2004.10.035, 15556141.
23. Yoshimura A, Longmore G, Lodish HF. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature 1990, 348:647-649. 10.1038/348647a0, 2174515.
24. Longmore GD, Pharr PN, Lodish HF. A constitutively activated erythropoietin receptor stimulates proliferation and contributes to transformation of multipotent, committed nonerythroid and erythroid progenitor cells. Mol Cell Biol 1994, 14:2266-2277. 358593, 8139532.
25. Watowich SS, Yoshimura A, Longmore GD, Hilton DJ, Yoshimura Y, Lodish HF. Homodimerization and constitutive activation of the erythropoietin receptor. Proc Natl Acad Sci USA 1992, 89:2140-2144. 10.1073/pnas.89.6.2140, 48612, 1312714.
26. Moucadel V, Constantinescu SN. Differential STAT5 signaling by ligand-dependent and constitutively active cytokine receptors. J Biol Chem 2005, 280:13364-13373. 10.1074/jbc.M407326200, 15677477.
27. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984, 11:47-60. 10.1016/0165-0270(84)90007-4, 6471907.
28. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 1997, 76:105-116.
29. Zucker RS, Regehr WG. Short-term synaptic plasticity. Annu Rev Physiol 2002, 64:355-405. 10.1146/annurev.physiol.64.092501.114547, 11826273.
30. Sweatt JD. Toward a molecular explanation for long-term potentiation. Learn Mem 1999, 6:399-416. 10.1101/lm.6.5.399, 10541462.
31. Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron 2004, 44:5-21. 10.1016/j.neuron.2004.09.012, 15450156.
32. Kogan JH, Frankland PW, Silva AJ. Long-term memory underlying hippocampus-dependent social recognition in mice. Hippocampus 2000, 10:47-56. 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6, 10706216.
33. Miskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ, Harmer CJ. Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study. Psychopharmacology (Berl) 2009, 207:133-142.
34. Chudasama Y, Passetti F, Rhodes SE, Lopian D, Desai A, Robbins TW. Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity. Behav Brain Res 2003, 146:105-119. 10.1016/j.bbr.2003.09.020, 14643464.
35. Kuroda M, Yokofujita J, Murakami K. An ultrastructural study of the neural circuit between the prefrontal cortex and the mediodorsal nucleus of the thalamus. Prog Neurobiol 1998, 54:417-458. 10.1016/S0301-0082(97)00070-1, 9522395.
36. Uylings HB, Groenewegen HJ, Kolb B. Do rats have a prefrontal cortex?. Behav Brain Res 2003, 146:3-17. 10.1016/j.bbr.2003.09.028, 14643455.
37. Rotaru DC, Barrionuevo G, Sesack SR. Mediodorsal thalamic afferents to layer III of the rat prefrontal cortex: synaptic relationships to subclasses of interneurons. J Comp Neurol 2005, 490:220-238. 10.1002/cne.20661, 16082676.
38. Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 2003, 160:1041-1052. 10.1176/appi.ajp.160.6.1041, 2919168, 12777258.
39. Takakusaki K, Saitoh K, Harada H, Kashiwayanagi M. Role of basal ganglia-brainstem pathways in the control of motor behaviors. Neurosci Res 2004, 50:137-151. 10.1016/j.neures.2004.06.015, 15380321.
40. Berridge KC, Kringelbach ML. Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology (Berl) 2008, 199:457-480.
41. Xiong Y, Mahmood A, Lu D, Qu C, Kazmi H, Goussev A, Zhang ZG, Noguchi CT, Schallert T, Chopp M. Histological and functional outcomes after traumatic brain injury in mice null for the erythropoietin receptor in the central nervous system. Brain Res 2008, 1230:247-257. 2593645, 18657521.
42. Xiong Y, Mahmood A, Qu C, Kazmi H, Zhang ZG, Noguchi CT, Schallert T, Chopp M. Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor. J Neurotrauma 2010, 27:205-215. 10.1089/neu.2009.1001, 2824224, 19715391.
43. Liu ZY, Chin K, Noguchi CT. Tissue specific expression of human erythropoietin receptor in transgenic mice. Dev Biol 1994, 166:159-169. 10.1006/dbio.1994.1304, 7958443.
44. Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, Gassmann M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA 1995, 92:3717-3720. 10.1073/pnas.92.9.3717, 42032, 7731971.
45. Liu C, Yu K, Shen K, Liu Z, Noguchi CT. Transgenic mice containing the human erythropoietin receptor gene exhibit correct hematopoietic and neural expression. Proc Assoc Am Physicians 1996, 108:449-454.
46. Knabe W, Knerlich F, Washausen S, Kietzmann T, Sirén AL, Brunnett G, Kuhn HJ, Ehrenreich H. Expression patterns of erythropoietin and its receptor in the developing midbrain. Anat Embryol (Berl) 2004, 207:503-512.
47. Knabe W, Sirén AL, Ehrenreich H, Kuhn HJ. Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root ganglia. Anat Embryol (Berl) 2005, 210:209-219.
48. Ehrenreich H, Hasselblatt M, Knerlich F, von Ahsen N, Jacob S, Sperling S, Woldt H, Vehmeyer K, Nave KA, Sirén AL. A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc Natl Acad Sci USA 2005, 102:862-867. 10.1073/pnas.0406008102, 545528, 15642952.
49. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 1999, 19:643-651.
50. Bernaudin M, Nedelec AS, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 2002, 22:393-403.
51. Constantinescu SN, Keren T, Socolovsky M, Nam H, Henis YI, Lodish HF. Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc Natl Acad Sci USA 2001, 98:4379-4384. 10.1073/pnas.081069198, 31843, 11296286.
52. Hepp S, Gerich FJ, Müller M. Sulfhydryl oxidation reduces hippocampal susceptibility to hypoxia-induced spreading depression by activating BK channels. J Neurophysiol 2005, 94:1091-1103. 10.1152/jn.00291.2005, 15872065.
53. Müller M, Somjen GG. Inhibition of major cationic inward currents prevents spreading depression-like hypoxic depolarization in rat hippocampal tissue slices. Brain Res 1998, 812:1-13. 10.1016/S0006-8993(98)00812-9, 9813218.
54. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004, 3:287-302. 10.1111/j.1601-1848.2004.00076.x, 15344922.
55. Humby T, Wilkinson L, Dawson G. Assaying aspects of attention and impulse control in mice using the 5-choice serial reaction time task. Curr Protoc Neurosci 2005, Chapter 8(Unit 8.5H).
56. Robbins TW. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 2002, 163:362-380.
57. Wrenn CC, Turchi JN, Schlosser S, Dreiling JL, Stephenson DA, Crawley JN. Performance of galanin transgenic mice in the 5-choice serial reaction time attentional task. Pharmacol Biochem Behav 2006, 83:428-440. 10.1016/j.pbb.2006.03.003, 16626795.
58. Humby T, Laird FM, Davies W, Wilkinson LS. Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype. Eur J Neurosci 1999, 11(8):2813-2823. 10.1046/j.1460-9568.1999.00701.x, 10457178.
59. Deacon RM. Digging and marble burying in mice: simple methods for in vivo identification of biological impacts. Nat Protoc 2006, 1(1):122-124. 10.1038/nprot.2006.20, 17406223.